Professional Documents
Culture Documents
RAKESH NAVRANG
Report Date :04/07/2022 15:56 Regi stration : ADMIT-782682 Cons ultant : Dr. --NA--
HPE/CPE # : 4912/22
CLINICAL DATA:
SAMPLE:
Fluid cytology from left upper cervical region Post MRND
MICROSCOPIC:
Smears made from cytocentrifuged sediment of fluid from left upper cervical region post MRND
are cellular and show inflammatory cells comprising mostly of neutrophils, few lymphocytes
and macrophages on the background of amorphous material and red blood cells.
Atypical cells not seen in smears studied.
IMPRESSION:
Inflammatory Exudate.
Report Date :01/06/2022 17:36 Regi stration : ADMIT-770862 Cons ultant : Dr. --NA--
HISTOPATHOLOGY (SMALL)
CLINICAL DATA:
SPECIMEN:
(i) WLE + left Hemimandible + left SA
(ii) Level I A lymph nodes
(iii) Left Level II, III, IV, V lymph nodes
MACROSCOPIC:
(i) Received a specimen of WLE + left Hemimandible + left SA measuring 9.5x8x4 cm
along lower alveolus 5 teeth and upper 3 teeth identified. An ulceroinfiltrative
growth is identified measuring 2x1.8x0.8 cm, involving left buccal mucosa, extending
upto left RMT. On serial sectioning the maximum depth of invasion of the tumor is
0.8 cm. The underlying mandibular bone grossly uninvolved. The distances of various
mucosal resection margins from the tumor are: lower alveolus anterior 2.5 cm,
upper alveolus anterior 1.2 cm, posterior 0.8 cm, inferomedial 1.5 cm, superomedial
2.5 cm, anterior buccal mucosa 0.7 cm.
Distance from tumor: lateral soft tissue resection base 0.4 cm, Salivary gland is
identified measuring 3x2.5x1.5 cm. Multiple lymph nodes identified ranging from 0.6
cm to 1.2 cm in diameter.
(ii) Level I A lymph nodes : A fibro-fatty soft tissue piece measuring 2x1.8x0.5 cm. 2
lymph nodes identified, one measuring 0.5 cm and other 0.8 cm in diameter.
(iii) Left Level II, III, IV, V lymph nodes : Fibro-fatty and fibromuscular soft tissue mass
measuring 9x6x4 cm. Multiple lymph nodes identified ranging from 0.2 cm to 1.5 cm
in diameter.
SECTIONS SUMMARY:
A-Anterior mucosal margin – lower alveolus B-Anterior mucosal margin – upper alveolus
C-Superomedial resection margin D-inferomedial resection margin
E-Posterior resection margin F-Anterior buccal mucosal resection margin
MICROSCOPIC:
Sections from left buccal mucosa growth show moderately differentiated squamous cell
carcinoma forming cords and sheets infiltrating in fibromuscular stroma. Perineural
tumour invasion seen. Lymphovascular emboli not seen. (Microscopic depth of invasion
9 mm). Tumor involving reteromolar mucosa.
Section from surgical resection base – free of tumor.
Sections from various mucosal resection margins (anterior, superomedial, inferomedial
and posterior) – free of tumor.
Section from salivary gland – free of tumor.
Section from left level I B lymph nodes (1/2) – show tumor metastasis.
Section from left level I A lymph nodes (2) – free of tumor.
Sections rom left level II, III, IV, V lymph nodes (1/23) – show tumor metastasis. ENE
present.
Section from anterior bony resection margin – free of tumor.
Section from bone beneath tumor – Free of tumour.
IMPRESSION:
Squamous Cell Carcinoma (Grade II) – Left Buccal mucosa with metastases to ipsilateral
cervical lymph nodes (2/27), ENE +.
Report Date :12/05/2022 11:31 Regi stration : ADMIT-770862 Cons ultant : Dr. --NA--
HPE/CPE # : 3234/22
CLINICAL DATA:
SPECIMEN:
Biopsy from Right Buccal Mucosa
MACROSCOPIC:
Multiple soft tissue bits aggregate measuring 1x0.5x0.2 cm. All tissue processed.
MICROSCOPIC:
The section shows bit of oral mucosa; stratified squamous epithelium showing hyperplasia.
Subepithelial tissue showing moderate lymphoplasmacytic infiltrate with pigment incontinence.
No evidence of dysplasia or malignancy in section studied.
IMPRESSION:
The features are suggestive of Lichenoid Lesion –Right Buccal mucosa .
PATHOLOGIST
Study done in various views shows normal size left atrium. Inter -atrial septum is intact. Right
atrium is of normal size.
Tricuspid valve is structurally normal. Trivial TR, RVSP~27mmHg+RAP. Right ventricle is placed
anteriorly & is normal. MPA is normal. Pulmonary valve cusps are normal.
Mitral valve cusps are normal in thickness & excursion. MV orifice area during diastole is normal.
Trivial MR.
LV cavity size is normal. No regional wall motion abnormalities at rest. LV systolic function is fair
thus over all LVEF is 60%.
Aortic valves is tricuspid, aortic systolic opening is full, diastolic closure is in center.
DIMENSIONS
Lvd. (Diastolic) - 42mm Lvd. (Systolic) - 25mm
RVD(diastolic) - IVST(diastolic) - 10mm
RADIOGRAM OF CHEST
(Patient is rotated)
Trachea is central.
CECT NECK
Report:
An ill-defined heterogeneous enhancing lesion is noted in the left buccal mucosa measuring
approximately 2.3 x 1.1 x 2.8 cm extending into the adjacent left sided retromolar trigone
involving both superior inferior gingivobuccal sulcal space. No underlying bony erosion is
noted.
Few lymph nodes are noted in the cervical region at station IA, bilateral station IB, IIA/B
measuring approximately 5-10 mm in short axis diameter.
A simple cyst of size 8 mm is seen in the posterior segment of the left upper lobe.
The visualized bones appear grossly unremarkable. Visualised nasopharynx, oropharynx and para
pharyngeal spaces including pterygo-palatine fossa region appear normal.
Supra glottic region reveals normal valleculae, pyriform sinuses and ary epiglottic folds. Vocal
cord appear normal. Visualised trachea appear normal.
Bilateral parotid glands, submandibular glands and thyroid glands appear normal.
The muscular / vascular structures and fascial planes with neck region appear normal.
Skull base and posterior fossa appear normal.
Paranasal sinuses appear normal.
Neck vessels appear normal.
Page 1 of 2 Patient Name : MR. RAKESH NAVRANG Registration : OPD -12371616
An ill-defined heterogeneous enhancing lesion is noted in the left buccal mucosa measuring
approximately 2.3 x 1.1 x 2.8 cm extending into the adjacent left sided retromolar trigone
involving both superior inferior gingivobuccal sulcal space. No underlying bony erosion is
noted.
Few lymph nodes are noted in the cervical region at station IA, bilateral station IB, IIA/B
measuring approximately 5-10 mm in short axis diameter.
Investigations have their limitations. Solitary radiological & other investigations never confirm the final diagnosis of the disease. They
only help in diagnosing the disease and correlation to clinical symptoms and other related tests is required. This is a profe ssional
opinion, not a diagnosis. Please interpret accordingly.
Neutrophils 59 % 40-70
Lymphocyte 34 % 20-45
Monocyte 05 % 2-10
Eosionophils 02 % 1-6
Basophils 00 % 0-1
Page 1 of 10
UHID : 4152709 Name : MR. RAKESH NAVRANG Sr. No. : 11014612
Reg. No. : ADMIT-770862 Age : 35 Y Sample Date : 07/05/2022 17:53
Accession No. : 2274558 Gender : MALE Report Date : 07/05/2022 19:40
Consultant : Dr. --NA-- Ward : 502 (M) - 5F OLD BLDG
PROTHROMBIN TIME
Test 15 Sec.
Control. 14 Sec. 13
INR 1.0
Ratio 1.0
P.T.T / A.P.T.T.
PTT of Test 31 Sec. 28 - 32 Sec.
PTT of Control 30
PATHOLOGIST
Page 2 of 10
R.D.W. H 14.9 % 11.60-14.00
Neutrophils H 89 % 40-70
Lymphocyte L 06 % 20-45
Monocyte 05 % 2-10
Eosionophils L 00 % 1-6
Basophils 00 % 0-1
PATHOLOGIST
Page 3 of 10
BIOCHEMISTRY
ALKALINE PHOSPHATASE
Alk. Phosphatase 76 lu/L Male < 270
Remark :
Disclaimer :
On Vitros Dry chemistry as per the method instructions ,since Total , Direct and Indirect bilirubin are measured independently it can mean that
sum of direct bilirubin and Indirect bilirubin may not be exactly equal to Total bilirubin result. The normally expected variability in the independent
measurements of Tbil, BU( Indirect), BC( Direct) will occasionally produce a sum of BU+BC that may be slightly greater or s l i g h t l y l e s s t h a n ( u p t o
+/-0.3mg/dl) the TBIl, even when the true concentrations of Bu+Bc and tbil are identical. Conjugated Bilirubin in plasma reacts to form the
bilirubin-albumin conjugate called as delta bilirubin. Delta bilirubin remains elevated for longer duration. Delta bilirubin remains elevated long
after biliary obstruction is cleared. Kindly correlate clinically.
Page 4 of 10
UHID : 4152709 Name : MR. RAKESH NAVRANG Sr. No. : 11014640
Reg. No. : ADMIT-770862 Age : 35 Y Sample Date : 07/05/2022 17:53
Accession No. : 2274559 Gender : MALE Report Date : 09/05/2022 10:05
Consultant : Dr. --NA-- Ward : 502 (M) - 5F OLD BLDG
S.G.P.T. (ALT)
S.G.P.T (ALT) H 103 u/l Male : < 50
S.G.O.T. (AST)
S.G.O.T. (AST). H 65 U/L 15-46
Page 5 of 10
UHID : 4152709 Name : MR. RAKESH NAVRANG Sr. No. : 11014644
Reg. No. : ADMIT-770862 Age : 35 Y Sample Date : 07/05/2022 17:53
Accession No. : 2274559 Gender : MALE Report Date : 09/05/2022 10:04
Consultant : Dr. --NA-- Ward : 502 (M) - 5F OLD BLDG
CREATININE
Serum Creatinine. 0.70 mg / dL 0.7-1.2
BLOOD UREA
UREA 19 mg/dL 15-40
CLINICAL BIOCHEMIST
Page 6 of 10
UHID : 4152709 Name : MR. RAKESH NAVRANG Sr. No. : 11087114
Reg. No. : ADMIT-770862 Age : 35 Y Sample Date : 26/05/2022 06:26
Accession No. : 2294413 Gender : MALE Report Date : 26/05/2022 09:54
Consultant : Dr. --NA-- Ward : 502 (M) - 5F OLD BLDG
Remark .
CLINICAL BIOCHEMIST
Page 7 of 10
SEROLOGY
Remark :
(Tridot Biotech Inc / Rapid Immunoconcentration - Retroquic/ELISA / Quick Chek HIV-I & II)
1. Single test performed for the demonstration of HIV-Antibody should be considered as screening test.
2.The above test performed for demonstration of HIV-Antibody gives false negative results if patient is in Window period (Viremic phase).
3.The above test performed for demonstration of HIV-Antibody gives false negative results in advance case of AIDS (Immune collapse phase).
4.The above test performed for demonstration of HIV-Antibody detects only Ig G type of HIV-Antibody.
5.If test advocated for newborn: Test performed for the demonstration of HIV-Antibody gives false negative results upto 18 months of age.
METHOD ELISA
Page 8 of 10
MICROBIOLOGIST
Page 9 of 10
VIROLOGY
LAB ID SAIMS/COV/AG/22/2758
Remark :
The STANDARD Q COVID - 19 Ag Test showed 84.38% of sensitivity.The STANDARD Q COVID - 19 Ag Test showed 100% of specificity
Limit of Detection (LoD): The study used SARS-CoV-2 (2019- n C O V ) N C C P 4 3 3 2 6 / 2 0 2 0 / K o r e a s t r a i n . T h e t i t e r o f c u l t u r e d v i r u s w a s c o n f i r m e d b y
PCR. The cell is inactivated and spiked into Nasopharyngeal swab specimen.The LoD is 1.25 X 103.2 TCID50 /ml.
The test should be used for the detection of SARS-CoV-2 antigen in human nasopharyngeal swab specimens.
Neither the quantitative value nor the rate of SARS-CoV-2 antigen concentration can be determined by this qualitative test.
A negative result may occur if the concentration of antigen or antibody in a specimen is below the detection limit of the test or if the specimen
was collected or transported improperly, therefore a negative test resul t d o e s n o t e l i m i n a t e t h e p o s i b i l i t y o f S A R S - C o V - 2 i n f e c t i o n , a n d s h o u l d b e
confirmed by viral culture or an molecular assay or ELISA.
Positive test results do not rule out co-infections with other pathogens.
Positive test results do not rule out co-infections with other pathogens.
Negative test results are not intended to rule in other coronavirus infection except the SARS-CoV.
BIBLIOGRAPHY:
- Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance. WHO.2020
- Diagnosis and treatment of pneumonia caused by new coronavirus (trial version 4) National Health Commission. 2020.
BIOCHEMISTRY
CREATININE
Serum Creatinine. L 0.64 mg / dL 0.7-1.2
Page 10 of 10
UHID : 4152709 Name : MR. RAKESH NAVRANG Sr. No. : 10970197
Reg. No. : OPD-12370449 Age : 35 Y Sample Date : 25/04/2022 15:59
Accession No. : 2262695 Gender : MALE Report Date : 26/04/2022 09:22
Consultant : Dr. SANJAY DESAI Ward :
BLOOD UREA
UREA L 14 mg/dL 15-40
CLINICAL BIOCHEMIST
HAEMATOLOGY
Neutrophils 70 % 40-70
Lymphocyte 23 % 20-45
Monocyte 05 % 2-10
Eosionophils 02 % 1-6
Basophils 00 % 0-1
Remark .
Page 1 of 1
Checked By : 14367 DR HARSHITA DEEP SAHU
PATHOLOGIST
Page 1 of 2
BIOCHEMISTRY
CREATININE
Serum Creatinine. L 0.65 mg / dL 0.7-1.2
BLOOD UREA
UREA 27 mg/dL 15-40
CLINICAL BIOCHEMIST
HAEMATOLOGY
Page 2 of 2
UHID : 4152709 Name : MR. RAKESH NAVRANG Sr. No. : 11233450
Reg. No. : OPD-12583646 Age : 35 Y Sample Date : 01/07/2022 10:15
Accession No. : 2333554 Gender : MALE Report Date : 01/07/2022 16:57
Consultant : Dr. VIRENDRA BHANDARI Ward :
Neutrophils H 79 % 40-70
Lymphocyte L 16 % 20-45
Monocyte 04 % 2-10
Eosionophils 01 % 1-6
Basophils 00 % 0-1
PATHOLOGIST
Page 1 of 2
BIOCHEMISTRY
BLOOD UREA
UREA 24 mg/dL 15-40
CREATININE
Serum Creatinine. 0.74 mg / dL 0.7-1.2
Remark .
CLINICAL BIOCHEMIST
Page 2 of 2
HAEMATOLOGY
Neutrophils H 80 % 40-70
Lymphocyte L 14 % 20-45
Monocyte 04 % 2-10
Eosionophils 02 % 1-6
Basophils 00 % 0-1
PATHOLOGIST
Page 1 of 3
BIOCHEMISTRY
BLOOD UREA
UREA 26 mg/dL 15-40
CREATININE
Serum Creatinine. L 0.67 mg / dL 0.7-1.2
CLINICAL BIOCHEMIST
Page 2 of 3
CLINICAL BIOCHEMIST
HAEMATOLOGY
Neutrophils H 87 % 40-70
Lymphocyte L 08 % 20-45
Monocyte 04 % 2-10
Eosionophils 01 % 1-6
Basophils 00 % 0-1
PATHOLOGIST
Page 3 of 3
BIOCHEMISTRY
BLOOD UREA
UREA 21 mg/dL 15-40
CREATININE
Serum Creatinine. L 0.61 mg / dL 0.7-1.2
CLINICAL BIOCHEMIST
Page 1 of 2
CLINICAL BIOCHEMIST
HAEMATOLOGY
Neutrophils H 82 % 40-70
Lymphocyte L 12 % 20-45
Monocyte 05 % 2-10
Eosionophils 01 % 1-6
Basophils 00 % 0-1
PATHOLOGIST
Page 2 of 2
BIOCHEMISTRY
CREATININE
Serum Creatinine. L 0.58 mg / dL 0.7-1.2
BLOOD UREA
UREA 22 mg/dL 15-40
CLINICAL BIOCHEMIST
Page 1 of 2
CLINICAL BIOCHEMIST
HAEMATOLOGY
Neutrophils H 89 % 40-70
Lymphocyte L 07 % 20-45
Monocyte 04 % 2-10
Eosionophils L 00 % 1-6
Basophils 00 % 0-1
Remark .
PATHOLOGIST
Page 2 of 2
BIOCHEMISTRY
CREATININE
Serum Creatinine. L 0.66 mg / dL 0.7-1.2
BLOOD UREA
UREA 25 mg/dL 15-40
CLINICAL BIOCHEMIST
Page 1 of 1